117 related articles for article (PubMed ID: 30155971)
1. Severe cutaneous eruptions following the topical use of preparations containing bufexamac: Is it time to reconsider its registration in Australia?
Harris AG; Saikal SL; Scurry J; Relic J; Nixon RL; Chee P
Australas J Dermatol; 2019 Feb; 60(1):53-56. PubMed ID: 30155971
[TBL] [Abstract][Full Text] [Related]
2. Allergic contact dermatitis to topical preparations of bufexamac.
Pan Y; Nixon R
Australas J Dermatol; 2012 Aug; 53(3):207-10. PubMed ID: 22881467
[TBL] [Abstract][Full Text] [Related]
3. [Contact allergies caused by bufexamac].
Geier J; Fuchs T
Med Klin (Munich); 1989 Jul; 84(7):333-8. PubMed ID: 2529420
[TBL] [Abstract][Full Text] [Related]
4. Acute generalized exanthematous pustulosis induced by bufexamac in an atopic girl.
Belhadjali H; Ghannouchi N; Njim L; Mohamed M; Moussa A; Bayou F; Chakroun M; Zakhama A; Zili J
Contact Dermatitis; 2008 Apr; 58(4):247-8. PubMed ID: 18353041
[No Abstract] [Full Text] [Related]
5. Allergic contact dermatitis with spreading over extensive regions due to topical use of 5% bufexamac ointment.
Arikawa J; Okabe S; Kaneko T
J Dermatol; 2004 Feb; 31(2):136-8. PubMed ID: 15160871
[No Abstract] [Full Text] [Related]
6. Allergic contact dermatitis from bufexamac cream.
Corazza M; Roveggio C; Virgili A
Contact Dermatitis; 1993 Oct; 29(4):219. PubMed ID: 8281796
[No Abstract] [Full Text] [Related]
7. [A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)].
Schnuch A; Gefeller O; Uter W
Dtsch Med Wochenschr; 2005 Dec; 130(50):2881-6. PubMed ID: 16342011
[TBL] [Abstract][Full Text] [Related]
8. [Severe contact dermatitis caused by Parfenac cream].
Collet E; Lacroix M; Boulitrop Morvan C; Dalac S; Sallin J; Lambert D
Ann Dermatol Venereol; 1993; 120(12):892-3. PubMed ID: 8074349
[TBL] [Abstract][Full Text] [Related]
9. [Bufexamac-induced pigmented purpuric eruption].
Waltermann K; Marsch WCh; Kreft B
Hautarzt; 2009 May; 60(5):424-7. PubMed ID: 19093092
[TBL] [Abstract][Full Text] [Related]
10. Photo Koebner phenomenon in erythema-multiforme-like eruption induced by contact dermatitis due to bufexamac.
Kurumaji Y
Dermatology; 1998; 197(2):183-6. PubMed ID: 9732173
[TBL] [Abstract][Full Text] [Related]
11. Erythema-multiforme-like, urticarial papular and plaque eruptions from bufexamac: report of 4 cases.
Koch P; Bahmer FA
Contact Dermatitis; 1994 Aug; 31(2):97-101. PubMed ID: 7750277
[TBL] [Abstract][Full Text] [Related]
12. [A severe epicutaneous test reaction to the bufexamac in a hemorrhoidal therapeutic preparation].
Bauer A; Greif C; Gebhardt M; Elsner P
Dtsch Med Wochenschr; 1999 Oct; 124(40):1168-70. PubMed ID: 10548947
[TBL] [Abstract][Full Text] [Related]
13. Contact dermatitis caused by bufexamac sparing the eruption of herpes zoster.
Fukuda H; Sato Y; Usami N; Yokouchi Y; Mukai H
J Dermatol; 2012 Apr; 39(4):405-7. PubMed ID: 21950459
[No Abstract] [Full Text] [Related]
14. Allergic contact dermatitis syndrome from bufexamac for nursing infant.
Nakada T; Matsuzawa Y
Dermatitis; 2012; 23(4):185-6. PubMed ID: 22828265
[No Abstract] [Full Text] [Related]
15. Bufexamac and diclofenac: frequency of contact sensitization and absence of cross-reactions.
Barbaud A; Tréchot P; Aublet-Cuvelier A; Reichert-Penetrat S; Schmutz JL
Contact Dermatitis; 1998 Nov; 39(5):272-3. PubMed ID: 9840280
[No Abstract] [Full Text] [Related]
16. Delayed contact hypersensitivity to non-steroidal anti-inflammatory drugs.
Gniazdowska B; Ruëff F; Przybilla B
Contact Dermatitis; 1999 Feb; 40(2):63-5. PubMed ID: 10048648
[TBL] [Abstract][Full Text] [Related]
17. [Contact allergy to bufexamac].
Frosch PJ; Raulin C
Hautarzt; 1987 Jun; 38(6):331-4. PubMed ID: 2958428
[TBL] [Abstract][Full Text] [Related]
18. [Severe allergic contact dermatitis with generalized spread due to bufexamac presenting as the "baboon" syndrome].
Proske S; Uter W; Schnuch A; Hartschuh W
Dtsch Med Wochenschr; 2003 Mar; 128(11):545-7. PubMed ID: 12635026
[TBL] [Abstract][Full Text] [Related]
19. Severe allergic contact dermatitis caused by topical bufexamac requiring hospitalization.
Wong GN; Shen S; Nixon R
Contact Dermatitis; 2019 Jun; 80(6):395-397. PubMed ID: 30624772
[No Abstract] [Full Text] [Related]
20. Epidemiological significance of bufexamac as a frequent and relevant contact sensitizer.
Kränke B; Szolar-Platzer C; Komericki P; Derhaschnig J; Aberer W
Contact Dermatitis; 1997 Apr; 36(4):212-5. PubMed ID: 9165205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]